Clinical Trial Update: International Registry for Primary Hyperoxaluria

View source ↗

Summary

The International Registry for Primary Hyperoxaluria, sponsored by Mayo Clinic, has been withdrawn from clinical trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria
• Nephrocalcinosis
• Nephrolithiasis

Snippet

Sponsor: Mayo Clinic | Conditions: Primary Hyperoxaluria, Nephrocalcinosis | Status: WITHDRAWN